I

t’s a holiday week. Things are slow. But we’re still keeping tabs on all things pharma and biotech. Here’s what we’re looking out for this week:

Bad news

If the goal is to bury bad news, this week is the time to do it. Whether it’s a bankruptcy, layoffs, or a decision to give up on an experimental drug, companies have plenty of incentive to get that press release out of the way while hardly anyone’s paying attention. (Don’t worry. We’ll be watching.)

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X